Log in to save to my catalogue

Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with...

Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2464151193

Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors

About this item

Full title

Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors

Publisher

New York: Springer US

Journal title

Bulletin of experimental biology and medicine, 2020-11, Vol.170 (1), p.64-68

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

The levels of sPD-1 and sPD-L1 were analyzed in blood serum of 132 patients (age 14-70 years) with primary bone tumors: osteosarcoma (
N
=39), chondrosarcoma (
N
=42), Ewing sarcoma (
N
=9), chordoma (
N
=12), giant-cell bone tumor (GCBT) (
N
=16), benign neoplasms (
N
=14) and in and practically healthy subjects...

Alternative Titles

Full title

Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone Tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2464151193

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2464151193

Other Identifiers

ISSN

0007-4888

E-ISSN

1573-8221

DOI

10.1007/s10517-020-05005-2

How to access this item